Influence of Noxious Electrical Stimulation on Chronic Pain From Knee Osteoarthritis
CompletedNot applicableNCT04628013
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Knee osteoarthritis (OA) is the most common lower extremity joint pain condition, and it is estimated that 15 million people in the US are living with symptomatic knee OA and that more than half (8 million) are under 65 years of age. To that end, the Centers for Disease Control and Prevention strongly recommends non-pharmacological treatments for chronic pain including physical therapy and weight loss; however, these interventions have significant barriers that can prevent their success. An intervention that targets pain specifically is transcutaneous electrical nerve stimulation (TENS), which is a low-cost intervention with evidence to support pain reduction. As used in the majority of research to date, the intervention called "TENS" refers to the application of electricity across the skin that produces a tingling sensation that is strong but comfortable. However, electricity is applied at a noxious level is thought to result in strong activation of the endogenous pain modulation system, thus producing longer-lasting pain inhibition. However, noxious electrical stimulation (NxES) has rarely been investigated as a treatment intervention. Recent studies, including our own, demonstrate that NxES produces immediate and potentially greater pain relief. Despite some promising research, the clinical use of NxES is sparse and more research is necessary to demonstrate its effects on resting pain, movement-related pain, physical function, and quality of life. The investigators hypothesize that the application of NxES will activate pain modulation mechanisms and change the pain modulation profile toward an anti-nociceptive state in adults with chronic knee osteoarthritis (OA) pain, and thereby decrease pain (at rest and with movement), improve physical function, and improve quality of life. The investigators expect individual differences; therefore, participants will be classified at baseline and their response to the intervention tracked using psychophysical tests and clinic…
Study details
- Official title
- Influence of Noxious Electrical Stimulation on Chronic Pain
- Conditions
- Interventions
- Device: Noxious Electrical Stimulation (NxES)
- Sponsor
- University of New England
- Start date
- 2021-08-02
- Primary completion
- 2022-12-31
- Sex
- All
- Age range
- from 50 Years to 90 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * follow instructions given in English * have chronic knee joint-related pain of at least 6-months duration with a pain rating of at least 30/100 mm (0 = no knee pain, 100 = worst imaginable knee pain) over the last 24-hrs. * report knee pain of at least 30/100 mm with walking, during sit-to-stand transfers, or during stair use Exclusion Criteria: * prior experience with NxES * knee joint injections in the last 3-months or during the time of study participation * history of total knee arthroplasty in the involved knee * history of other surgery during the previous 6-months * history of fibromyalgia or other chronic pain condition * history of rheumatoid arthritis or related condition * history of neurologic disorders * history of cardiovascular or pulmonary disorders that would prevent the completion of the sit-to-stand test * physician-diagnosed Raynaud's Syndrome * history of diabetes with diminished sensation * history of dementia/cognitive impairment
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04628013